Human albumin (Shenzhen Weiguang)

人血白蛋白（深圳卫武光明）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman albumin (Shenzhen Weiguang)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Global Approved IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Approved Indications in ChinaShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Weiguang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Weiguang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeB05AA01
Related LinksWikipediaDrugBankKEGG